Webinar Recordings Archive

2016-

2015-

2014-

2013-

2012-

2011-

2010-

2009-

2008


Click here to access archived webinars located in the ISCT Store.  Note: ISCT members receive access to the slides and audio recording 6 months after the event.

2016

  October 26

Derivation, Expansion and Quality Control of Human MSCs for GMP-grade Cell Manufacturing in Monolayer & Suspension Cultures
Sponsored by Miltenyi Biotec
Organized by the ISCT Asia Regional Executive Committee

   October 25

Calling All ESPs - AMA (Ask Me Anything) with ISCT President Dr. Catherine Bollard
Organized by the ISCT Early Stage Professionals Committee

  October 19

A New Dawn of Stem Cell Medicine or Unfettered Patient Exploitation? Lessons from Unregulated Clinics in Australia and Japan

Organized by the ISCT Australia & New Zealand Legal & Regulatory Affairs Committee

  September 7

Conducting Validation Studies for Shipping of Cells
Organized by the ISCT North America Legal & Regulatory Affairs Committee

  April 26

Forecasting Cost of Goods for Cell Therapies to Guide Manufacturing Process Development
Sponsored by Pall Life Sciences
Organized by the ISCT Business Models & Cost of Goods Subcommittee

  March 2

Emergency Preparedness – From Hurricanes to Hetastarch
Organized by the ISCT Lab Practices Committee

  February 26

The New Regulatory Framework for Regenerative Medicine in Japan
Sponsored in Part by Stempeutics
Organized by the ISCT Asia Regional Executive Committee

 

2015

February 4

3D Printing Technologies
Organized by the ISCT Process and Product Development (PPD) Committee

April 29

Measurement Assurance for Cell Enumeration
Organized by the ISCT North American Legal and Regulatory Affairs (LRA) Committee

June 17

Utilizing a Risk-Based Approach for the Development of Media
Sponsored by Irvine Scientific

September 16

Media Use During Scale Up
Organized by the ISCT Immunotherapy Committee

October 14

A Comparative Analysis of Using Serum and Serum-Free Culture Systems for Generating Therapeutic Grade Human Mesenchymal Stem Cells
Sponsored by Irvine Scientific

October 21

Viability Determination of Cellular Therapy Products- The Need for Controlled Objective Analysis
Organized by the North America Legal and Regulatory Affairs (LRA)

November 18

Optimizing Cold Chain Logistics and Costs: Tips for Product Planning, Storage and Distribution
Organized by the ISCT Business Models and Cost of Goods Committee
Sponsored by BioLife Solutions


December 9

Thinking Beyond Efficacy, 4 Key Considerations for Commercial Success
Sponsored by Invetech

 

2014

February 26, 2014

What's in the Box: Unraveling the Mystery
Organized by the ISCT Lab Practices Committee

May 28, 2014

LabSmart Modelling 
Complimentary Webinar Sponsored by London Regenerative Medicine Network

August 21, 2014

Cadriac ANZ
Organized by the ISCT ANZ Regional Executive Committee

October 1, 2014

Therapeutic Potential Regulatory T Cells
Organized by the ISCT Lab Practices Committee

October 22, 2014

Building Deliverable Cell Therapeutics: A Methodical Approach to Manufacturing Development
Complimentary Webinar Sponsored by PCT

November 12, 2014

Environmental Monitoring of Clean Room Facilities for cGMP Compliant Manufacturing
Organized by the ISCT NA LRA Committee

November 25, 2014

Cell Therapy Clinical Trials in the EU
Organized by the ISCT Europe Regional Executive Committee


2013

January 23
12pm ET

How to meet GMP's for phase 1 trials
Organized by the NA LRA

February 6
12pm ET

Risk Evaluation Management
Organized by the CC

Febrary 27
12pm ET

Facility Size and Challenges in the Lab: More Volume, More Problems?
Organized by the LPC

March 27
12pm ET

How to always be inspection-ready
Organized by the NA LRA

May 08
12pm ET

Validation Requirements for Computerized Systems
Organized by the LPC

June 05
9am ET

Preclinical PK/PD analysis of cell therapies vs. small molecules
Organized by the CC

June 17
12pm ET

ATMP Regulations
Organized by the EU Regional Leadership Committee and EU LRA

July 31
12pm ET

Practical Guide to INDs/IDEs
Organized by the NA LRA

October 16
12pm ET

Generation of Antigen-Specific T Cells
Organized by the AUS/NZ Regional Executive Committee

November 05
12pm ET

COGs Survey: Results and Red Flags 
Organized by the CC

November 06
12pm ET

Preparing the Lab for a New Clinical Trial
Organized by the LPC

November 13
12pm ET

CliniMACS Prodigy: Cell Processing
Complimentary Webinar Sponsored by Miltenyi Biotec

November 20
12pm ET

Towards Bioengineered Control of Cell Fate
Organized by CC

November 25
12pm ET
Technological Advances in Contamination Testing
Organized by NA LRA


2012

January 17
12pm ET

Ancillary Materials Used in Cell Manufacturing
Organized and hosted by United States Pharmacopeia

February 8
12pm ET

Volume reduction technology for large scale harvest or post-thaw manipulation of cellular therapeutics
Organized by the CC

Febrary 22
12pm ET

Clean Room Facilities: Cleaning Best Practices
Organized by the LPC

April 11
12pm ET

Novel Methods for reducing CoGs in Autologous Processing
Organized by the CC

May 9
12pm ET

Quality control of manipulated and cryopreserved grafts
Organized by the LPC

May 25
9am ET

Potency Assays for Mesenchymal Tissue Regeneration
Organized by the EU LRA

June 20
12pm ET

The Circular of Information Basics: what it is and what it is not
Organized by the NA LRA

September 19
12pm ET

Best Practices in Process Development
Organized by the CC

September 26
12pm ET

ISBT Implementation: What to do and what not to do
Organized by the LPC

October 24 Postponed until further notice
12pm ET

Comparability
Organized by the CC

November 7
12pm ET

Training/Competency Program for CT Facilities
Organized by the LPC

November 21 Postponed until January 30th, 2013
12pm ET

How to Meet GMPs for Phase 1 Trials
Organized by the NA LRA

November 28
12pm ET

Electronic Records: What it means to be 21CFR part 11 compliant
Organized by the NA LRA

December 12
12pm ET

ISCT: Membership has its benefits.
Organized by ISCT Head Office

 

 

2011

February 16
12pm ET

Vendor Qualifications
Organized by the ISCT Laboratory Practices Committee

March 9
12pm ET

Potency Testing
Organized by the ISCT Commercialization Committee

March 16
12pm ET

Modified T-Cells: The implications of their use in the arenas of HIV and Cancer
Organized by the ISCT Legal and Regulatory Affairs Committee

April 13
12pm ET

Software for Cellular Therapy Facilities: Homemade versus Commercial and why Facilities chose what they did
Organized by the ISCT Lab Practices Committee

June 15
12pm ET

Emerging Issues n Cryopreservation for Cellular Therapies
Organized by the ISCT Legal and Regulatory Affairs Committee

September 14
12pm ET

Placental Derived Mesenchymal Cells - Isolation, Processing and Characterization
Organized by the ISCT Lab Practices Committee

November 2
12pm ET

Potency Testing
Organized by the ISCT Legal and Regulatory Affairs Committee

November 9
11am ET

hESC Manufacturing
Organized by the ISCT Commercialization Committee

November 16
12pm ET

CD34 Enumeration, How and When 2011
Organized by the ISCT Lab Practices Committee

 

 

2010

February 17
12pm ET

ISBT 128 Labeling for Cellular Therapy
Organized by the ISCT Laboratory Practices Committee

March 10
12pm ET

Transportation of HCT/Ps from UCB, BM and PBSC

June 9
12pm ET

Auditing: Tips, Tools and Techniques

September 22
1pm ET

Challenges Associated wtih Implementing a New Database/Data Management System
Sponsored by STEMSOFT Software

October 27
12pm ET

Business and Quality Agreements for the Cell Therapy Facility

November 10
12pm ET

GXP Requirements in Translational Research - From Bench to Bedside

 

 

2009

February 18
12pm ET

Part 1: Validation and Qualification of Equipment and Reagents
Sponsored by the ISCT Laboratory Practices Committee

March 25
12pm ET

Part 2: Validation of Processes: Retrospective and Prospective
Sponsored by the ISCT Laboratory Practices Committee

April 22
12pm ET

Batch Records for Cell Therapy Products
Sponsored by the ISCT North American Legal and Regulatory Affairs Committee

June 24
12pm ET

Risk Management Approach for Cell Therapeutics with Case Studies
Sponsored by the ISCT North American Legal and Regulatory Affairs Committee

September 9
12pm ET

Stability Testing and Optimization - Considerations for Cell Therapy Products
Sponsored by the ISCT North American Legal and Regulatory Affairs Committee

October 21
12pm ET

FDA Inspections for Cell Therapy Products from the Perspective of Hospitals and Industry
Sponsored by the ISCT North American Legal and Regulatory Affairs Committee

November 18
12pm ET

Sterility Testing for Cellular Therapy Product
Sponsored by the ISCT Laboratory Practice Committee

December 16
2pm ET

Distribution of Unrelated Manipulated Cord Blood in or to the U.S. after October 20, 2011, a Domestic and International Perspective
Sponsored by the ISCT North American Legal and Regulatory Affairs Committee

 

2008

March 19
12pm ET

Cellular Therapy Products: Lot Release Testing
Sponsored by the ISCT North America Legal and Regulatory Affairs Committee

April 30
12pm ET

Allogeneic versus Autologous Cell Therapy: Challenges and Differences
Sponsored by the ISCT North America Legal and Regulatory Affairs Committee

June 11
4pm ET

Quality Systems: Implementation and Oversight
Sponsored by the ISCT Lab Practices Committee

July 16
12pm ET

Contamination Control by Design
Sponsored by the ISCT North America Legal and Regulatory Affairs Committee

September 10
12pm ET

Demystifying FDA’s requirements: How to review and implement cell therapy regulations and guidance
Sponsored by the ISCT North America Legal and Regulatory Affairs Committee

October 22
12pm ET

Storage of Cellular Therapy Products: Issues Related to Duration, Discard and Quarantine
Sponsored by the ISCT Lab Practices Committee

 

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.